GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $206,000 | -52.6% | 5,474 | -48.7% | 0.07% | -57.3% |
| Q2 2020 | $435,000 | +1.4% | 10,671 | -5.8% | 0.16% | -16.8% |
| Q1 2020 | $429,000 | -18.1% | 11,330 | +1.7% | 0.20% | -9.2% |
| Q4 2019 | $524,000 | +13.4% | 11,146 | +3.0% | 0.22% | -2.3% |
| Q3 2019 | $462,000 | +14.9% | 10,825 | +7.8% | 0.22% | +0.9% |
| Q2 2019 | $402,000 | +6.3% | 10,042 | +11.0% | 0.22% | -15.1% |
| Q1 2019 | $378,000 | +14.2% | 9,043 | +4.4% | 0.26% | -13.1% |
| Q4 2018 | $331,000 | – | 8,658 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |